Primary Recipient

SIALIX, INC.

Amount

$152,526.00

Award Date

9/25/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Possible development of diagnostic products for Rheumatoid Arthritis. Specifically, these diagnostics will identify patients who have disease exacerbations due to Neu5Gc accumulation in joints from dietary sources combined with certain anitNeu5Gc antibodi